Myocardial infarction risk and hormone replacement: Differences between products

Maturitas

Volumn 53, Issue 3, 2006, Pages 343-350

  De Vries, C S ^a   Bromley, S E ^a   Farmer, R D T ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Hormone replacement therapy; Myocardial infarction; Risk assessment

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE; ESTRADIOL DERIVATIVE; ESTRIOL; ESTROGEN DERIVATIVE; ESTRONE DERIVATIVE; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; MESTRANOL; NORETHISTERONE; PIPERAZINE ESTRONE SULFATE; TIBOLONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG USE; FEMALE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POPULATION BASED CASE CONTROL STUDY; TREATMENT DURATION;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 31544449969     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.06.004     Document Type: Article

References (21)

1. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
2. D. Grady, D. Herrington, and V. Bittner Cardiovascular outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
3. S.E. Bromley, C.S. de Vries, D. Thomas, and R.D.T. Farmer Hormone replacement therapy and myocardial infarction: a review of the literature Drug Saf 28 6 2005 473 493
4. D.K. Wysowski, L. Golden, and L. Burke Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992 Obstet Gynecol 85 1995 6 10
5. R.D. Langer Progestins: pharmacologic characteristics and clinically relevant differences Int J Fertil 45 2000 63 72
6. SE. Bromley, CS. de Vries, and RDT. Farmer Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the General Practice Research Database Br J Obstet Gynaecol 111 4 2004 369 376
7. Million Women Study Collaborators Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000 Br J Obstet Gynaecol 109 2002 1319 1330
8. M.R. Adams, J.R. Kaplan, and S.B. Manuck Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone Arteriosclerosis 10 1990 1051 1057
9. M.R. Adams, T.C. Register, D.L. Golden, J.D. Wagner, and K. Williams Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis Arterioscler Thromb Vasc Biol 17 1997 217 221
10. K. Miyagawa, J. Rosch, F. Stanczyk, and K. Hemsmeyer Medroxyprogesterone interferes with ocarian steroid protection against coronary vasospasm Nat Med 3 1997 324 327
11. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 273 1995 199 208
12. T. Lancaster, G. Surman, M. Lawrence, D. Mant, M. Vessey, and M. Thorogood Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records J Epidemiol Community Health 49 4 1995 389 394
13. J. Hollowell The General Practice Research Database: quality of morbidity data Pop Trend 87 1997 36 40
14. H. Jick, L.E. Derby, V. Gurewich, and C. Vasilakis The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension Pharmacotherapy 16 1996 321 326
15. R.D. Mann, Y. Lis, J. Chukwujindu, and D.O. Chanter A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women J Clin Epidemiol 47 1994 307 312
16. C. Varas-Lorenzo, L.A. Garcia-Rodriguez, S. Perez-Gutthann, and A. Duque-Oliart Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study Circulation 101 2000 2572 2578
17. S. Sidney, D.B. Petitti, and C.P. Quesenberry Jr. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women Ann Intern Med 127 1997 501 508
18. L. Rosenberg, J.R. Palmer, and S. Shapiro A case-control study of myocardial infarction in relation to use of estrogen supplements Am J Epidemiol 137 1993 54 63
19. S.R. Heckbert, N.S. Weiss, and T.D. Koepsell Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women Arch Intern Med 157 1997 1330 1336
20. B.E. Henderson, A. Paganini-Hill, and R.K. Ross Decreased mortality in users of estrogen replacement therapy Arch Intern Med 151 1991 75 78
21. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res 53 3 2002 605 619